Cargando…
AURKA Increase the Chemosensitivity of Colon Cancer Cells to Oxaliplatin by Inhibiting the TP53-Mediated DNA Damage Response Genes
AURKA, a cell cycle-regulated kinase, is associated with malignant transformation and progression in many cancer types. We analyzed the expression change of AURKA in pan-cancer and its effect on the prognosis of cancer patients using the TCGA dataset. We revealed that AURKA was extensively elevated...
Autores principales: | Shan, Baocong, Zhao, Ran, Zhou, Jian, Zhang, Minghui, Qi, Xiaoyu, Wang, Tianzhen, Gong, Jinan, Wu, Yiqi, Zhu, Yuanyuan, Yang, Weiwei, Zhang, Yang, Wang, Guangyou, Li, Xiaobo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439175/ https://www.ncbi.nlm.nih.gov/pubmed/32851091 http://dx.doi.org/10.1155/2020/8916729 |
Ejemplares similares
-
The aberrant expression of rhythm genes affects the genome instability and regulates the cancer immunity in pan‐cancer
por: Zhou, Jian, et al.
Publicado: (2020) -
Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53(null) Cell Lines
por: Silden, Elisabeth, et al.
Publicado: (2013) -
Knockout of SIRT4 decreases chemosensitivity to 5-FU in colorectal cancer cells
por: Zhu, Yuanyuan, et al.
Publicado: (2018) -
DNAJB8 in small extracellular vesicles promotes Oxaliplatin resistance through TP53/MDR1 pathway in colon cancer
por: Wang, Zheng, et al.
Publicado: (2022) -
CCNB2 and AURKA overexpression may cause atypical mitosis in Japanese cortisol-producing adrenocortical carcinoma with TP53 somatic variant
por: Ikeya, Akira, et al.
Publicado: (2020)